Inventor
Darren H. Wakefield
Inventor
Fitchburg, WI, US
Overview
Patents· 48 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
C12NMicroorganisms or enzymes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07HSugars4%
C07KPeptides4%
A01KAnimal husbandry4%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds3%
C08LCompositions of macromolecular compounds2%
Y02ATechnologies for adaptation to climate change2%
B23DPlaning1%
PatentTitleYear
10,927,373Compositions and methods for inhibiting gene expression of Hif2alpha202110,858,658Compositions and methods for inhibiting gene expression of factor XII202010,806,750RNAi therapy for hepatitis B virus infection202010,780,108RNAi agents for Hepatitis B virus infection202010,662,427Compositions and methods for inhibiting gene expression of LPA202010,316,316Compositions for targeted delivery of siRNA201910,308,941Compositions and methods for inhibiting gene expression of factor XII201910,246,709Targeting ligands for therapeutic compounds201910,130,651RNAi Therapy for Hepatitis B Virus Infection201810,047,361Disulfide-containing alkyne linking agents201810,006,025Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin20189,976,141Compositions and methods for inhibiting gene expression of Hif2alpha20189,932,586Compositions and methods for inhibiting gene expression of LPA20189,803,201'Disulfide-containing alkyne linking agents'20179,803,205'Compositions and methods for inhibiting gene expression of factor XII'20179,796,756'Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA'20179,526,796'Peptide-based in vivo siRNA delivery system'20169,474,804'Poly(vinyl ester) polymers for in vivo nucleic acid delivery'20169,452,221'Poly(acrylate) polymers for in vivo nucleic acid delivery'20169,345,775'Compositions for targeted delivery of siRNA'20169,249,179'Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA'20169,107,957'Peptide-based in vivo siRNA delivery system'20159,089,611'Poly(vinyl ester) polymers for in vivo nucleic acid delivery'20159,011,919'Compositions for targeted delivery of siRNA'20158,933,047'Poly(acrylate) polymers for in vivo nucleic acid delivery'20158,932,572'Poly(vinyl ester) polymers for in vivo nucleic acid delivery'20158,802,773'In vivo polynucleotide delivery conjugates having enzyme sensitive linkages'20148,658,211'Polyconjugates for in vivo delivery of polynucleotides'20148,501,930'Peptide-based in vivo siRNA delivery system'20138,426,554'In vivo polynucleotide delivery conjugates having enzyme sensitive linkages'20138,313,772'Compositions for targeted delivery of siRNA'20128,217,015'Endosomolytic polymers'20128,211,468'Endosomolytic polymers'20128,137,695'Polyconjugates for in vivo delivery of polynucleotides'20128,138,383'Membrane active heteropolymers'20128,017,109'Endosomolytic poly(acrylate) polymers'20118,008,355'Endosomolytic poly(vinyl ether) polymers'20117,985,406'Membrane active heteropolymers'20117,871,818'Membrane active polymers'20117,816,337'Reversible attachment of a membrane active polymer to a polynucleotide'20107,682,626'Polyvinylethers for delivery of polynucleotides to mammalian cells'20107,501,394'Compounds for targeting hepatocytes'20097,470,539'Formation of polyampholytes in the presence of a polyion'20087,442,764'Reversible modification of amine-containing compounds'20087,348,453'Labile linkage for compound delivery to a cell'20087,094,605'Formation of polyampholytes in the presence of a polyion'20067,071,163'Compounds for targeting hepatocytes in vivo'20067,019,113'Reversible modification of membrane interaction'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2021Based in Fitchburg, WI, US· patent location history
2006–2008Based in Madison, WI, US· patent location history
2012–2018Patents assigned to ARROWHEAD MADISON INC (24)· patent assignee history
2012–2016Patents assigned to ROZEMA DAVID B (12)· patent assignee history
2012–2016Patents assigned to WAKEFIELD DARREN H (12)· patent assignee history
2012–2016Patents assigned to LEWIS DAVID L (8)· patent assignee history
2016–2021Patents assigned to ARROWHEAD PHARMACEUTICALS INC (19)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARROWHEAD MADISON INC | 24 | 2012–2018 |
| ARROWHEAD PHARMACEUTICALS INC | 19 | 2016–2021 |
| ROZEMA DAVID B | 12 | 2012–2016 |
| WAKEFIELD DARREN Hself | 12 | 2012–2016 |
| LEWIS DAVID L | 8 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Fitchburg, WI, US | 46 | 2006–2021 |
| Madison, WI, US | 2 | 2006–2008 |